Standards of Care in Diabetes 2024 Update for Early Career Professionals | Recording-Standards of Care in Diabetes 2024 Update for Early Career Professionals

Video Transcription

Video Summary

In this webinar summary, Dr. Robert Gabay presents the 2024 updates in standards of care for diabetes. The webinar covers a wide range of topics, including type 1 diabetes, bone health, diabetes technology, obesity, and cardiovascular disease risk reduction. Dr. Gabay highlights the importance of early screening for type 1 diabetes using specific antibodies, as well as the use of teplizumab to delay the development of the disease. He also discusses the increased risk of fracture and osteoporosis in people with type 1 and type 2 diabetes, and the importance of screening and treatment for bone health. In terms of technology, Dr. Gabay emphasizes the recommendation for all individuals on insulin to be offered a continuous glucose monitor. He also discusses the use of pharmacological therapy for obesity and the role of GLP-1 receptor agonists and SGLT2 inhibitors in the treatment of type 1 and type 2 diabetes. Finally, Dr. Gabay addresses the importance of cardiovascular disease risk reduction, including the use of statins and new recommendations for screening for heart failure and peripheral arterial disease. Overall, the webinar provides a comprehensive overview of the latest updates in diabetes care and treatment, and highlights the importance of personalized and person-centered care in managing the disease.

Keywords

webinar summary

Dr. Robert Gabay

2024 updates

diabetes

type 1 diabetes

bone health

diabetes technology

obesity

cardiovascular disease risk reduction